Evidence for ATP and noradrenaline as cotransmitters in sympathetic nerves.
Burnstock
G
G
Sneddon
P
P
D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*; D000320:Adrenergic Fibers / Q000502:physiology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D003042:Cocaine / Q000494:pharmacology; D004558:Electric Stimulation; D006168:Guinea Pigs; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D008954:Models, Biological; D009119:Muscle Contraction / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000502:physiology*; D009638:Norepinephrine / Q000502:physiology*; D016627:Oxidopamine; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D012110:Reserpine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D014649:Vas Deferens / Q000294:innervation
D000317:Adrenergic alpha-Antagonists; D006892:Hydroxydopamines; D018377:Neurotransmitter Agents; D011942:Receptors, Adrenergic, alpha; D012110:Reserpine; D016627:Oxidopamine; D000255:Adenosine Triphosphate; D003042:Cocaine; C002630:alpha,beta-methyleneadenosine 5'-triphosphate; D009638:Norepinephrine